Table 2.
Medications and clinical reasoning for patients with non-standard initial anti-tuberculosis treatment.
| The drug not prescribed in initial anti-TB regimena | |
| Isoniazid | 4 (8%) |
| Rifampin | 8 (16%) |
| Ethambutol | 17 (34%) |
| Pyrazinamide | 30 (60%) |
| The clinical reasons for exclusion of drugs in standard initial anti-TB regimenb | |
| Eye disease | 19 (38%) |
| Skin rashes | 2 (4%) |
| Elderly age or multiple comorbidities | 9 (18%) |
| Liver disease | 26 (53%) |
| Gout/hyperuricemia | 19 (38%) |
| Other | 4 (8%) |
aFive patients did not receive > 1 first-line anti-TB drugs. Four did not receive isoniazid, rifampin, or pyrazinamide. One did not receive rifampicin or pyrazinamide.
bThere were 2 patients with 4 reasons, 5 with 3 reasons, and 13 with 2 reasons for not being prescribed the standard initial anti-TB regimen.
TB tuberculosis.